Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

Edwards Lifesciences to buy Israel's Valtech for up to $690 mln


Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years. Valtech is a private company that developed a system for transcatheter repair of the heart's mitral and tricuspid valves.



from Biotech News